Growth Factor Restriction is a therapeutic strategy involving the intentional and temporary downregulation of specific anabolic signaling pathways, such as the Insulin/IGF-1 axis, often achieved through dietary or pharmacological means. The clinical objective is to mimic the biological effects of nutrient scarcity, thereby activating cellular maintenance and repair processes, including autophagy and DNA repair. This strategic restriction is employed to enhance cellular resilience and promote longevity mechanisms.
Origin
This concept is rooted in the extensive research on caloric restriction and intermittent fasting, which demonstrated that reduced nutrient signaling extends lifespan in various organisms. It shifts the focus from simple calorie counting to the specific modulation of nutrient-sensing pathways. “Restriction” refers to the targeted dampening of the signaling cascade, not the complete elimination of growth factors.
Mechanism
The primary mechanism involves the transient suppression of the Insulin/IGF-1 and mTOR pathways, which are typically activated by nutrient availability. Lowered signaling from these growth factors disinhibits key longevity pathways, such as the AMPK and sirtuin pathways. This shift in cellular signaling redirects energy away from growth and proliferation and towards stress resistance, mitochondrial biogenesis, and the removal of damaged cellular components through enhanced autophagy.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.